Cancer Cells Self-Destruct When "Sweet Tooth" Is Thwarted

"We knew very quickly that the cells we had altered to resemble cancers were dying off in large numbers."

Johns Hopkins researchers have found evidence that some cancer cells are such incredible sugar junkies that they'll self-destruct when deprived of glucose, their biological sweet of choice.

"The change when we took away glucose was dramatic," says Chi Van Dang, M.D., Ph.D., director of hematology. "By the next day, we knew very quickly that the cells we had altered to resemble cancers were dying off in large numbers."

Scientists have long suspected that the cancer cell's heavy reliance on glucose, its main source of strength and vitality, also could be one of its great weaknesses, and Dang's new results are among the most direct proofs yet of the idea.

Results of the study, published in the February 17 issue of the Proceedings of the National Academy of Sciences, suggest that drugs which cut off the glucose supply may be a potent way of fighting cancer with few ill effects on healthy tissues.

With funding from the National Institutes of Health, Hyunsuk Shim, Ph.D., a postdoctoral fellow, Dang and others gave embryonic mouse cells an unusually active form of a gene known as c-Myc. Many cancer cells overuse this gene, mass-producing its protein to start chain reactions that help them switch from using oxygen for energy production to using glucose.

"When we bathed cells with high c-Myc levels in a cell medium with no glucose, they destroyed themselves by triggering a cell suicide process called apoptosis," says Dang. "Cells we hadn't altered stopped moving through the cellular life cycle, staying in the first two stages of cell development, and appeared fine in all other regards."

Dang produced similar results by exposing both types of cells to 2-deoxyglucose, a compound that resembles sugar but disrupts glycolysis, t

Contact: Michael Purdy
Johns Hopkins Medical Institutions

Page: 1 2

Related biology news :

1. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Cancer gene MYC emerging as key research target
5. Cancer patient, heal thyself
6. USC researcher named General Motors Cancer Research Scholar
7. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
8. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
9. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
10. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
11. National Cancer Gene Therapy Foundation gives $4.0 million in research grants

Post Your Comments:

(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
Breaking Biology Technology:
Cached News: